Skip to main content

Table 1 Baseline characteristics in pharmacist consultation group and control group:

From: The efficacy of single pharmacist medication review among type II diabetic patients who take six chronic medications or more: a case–control study

Variable Pharmacist consultation group (N = 740) Control group (N = 1476) p-value
Age (years, Mean; SD) 70.0 ± 11.5 70.3 ± 11.6 0. 540
Female N (%) 351 (47.4) 698 (47.2) 0.950
Socio-economic status score (Mean; SD) 12.34 ± 17.5 12.5 ± 17.0 0.450
Chronic medications N (Mean; SD) 11.4 ± 2.4 9.9 ± 2.4 0.001
DM (N, %) 547 (73.9) 1092 (73.9) 0.973
HTN (N, %) 648 (87.5) 1329 (90.0) 0.074
Dyslipidemia (N, %) 645 (87.1) 1261 (85.4) 0.261
Homebound (N, %) 117 (15.8) 249 (16.8) 0.524
HbA1c* (Mean; CI) 7.21 ± 1.7 6.92 ± 1.3 0.001
SBP (mmHg)* (Mean; SD) 134.9 ± 19.3 134.3 ± 17.1 0.433
DBP (mmHg)* (Mean; SD) 68.2 + 25.1 75.50 ± 9.8 0.001
Total Cholesterol (mg/dl)* (Mean; SD) 175.6 ± 44.4 168.7 ± 37.8 0.001
TG (mg/dl)* (Mean; SD) 160.6 ± 87.9 156.0 ± 85.9 0.571
HDL Cholesterol (mg/dl) * (Mean; SD) 45.6 ± 11.8 45.4 + 12.4 0.753
LDL Cholesterol (mg/dl)* (Mean; SD) 98.7 ± 35.5 92.4 ± 31.1 0.001
  1. DM, Diabetes Mellitus; HTN, Hypertension; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; T. Cholesterol, Total Cholesterol; TG, Triglycerides
  2. *For patients with the relevant chronic disease